A Compound Heterozygote Case of Type II Aldosterone Synthase Deficiency
Authors:
Open Access
- 1 June 2003
- journal article
- case report
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 88 (6) , 2518-2526
Abstract
An infant with failure to thrive, persistent hyponatremia and episodic vomiting and diarrhea was admitted to hospital at 9 months of age, and the diagnosis of type II aldosterone synthase deficiency was confirmed by plasma and urinary steroid determinations. The entire coding sequence of the aldosterone synthase gene (CYP11B2) was determined (both strands) in the affected infant, an unaffected sibling, and both parents. An exon 3 mutation (C554T, leading to amino acid T185I) was found in the father and both siblings, and an exon 9 mutation (A1492G, leading to T498A) was found in the affected infant and the mother. Expression of the mutant sequences in COS cells showed steroidogenic patterns typical of aldosterone synthase type II deficiency, including very low levels of aldosterone synthesis (≤0.5% of wild-type enzyme) consistent with the low aldosterone levels in the patient’s plasma. Both mutations in this compound heterozygote localize to the β3-sheet in the cytochrome P450 enzyme structure, as does the previously characterized R181W mutation. This region of the enzyme is not part of the putative structural core, but mutations to this region suggest that it is important for conferring the unique ability of aldosterone synthase to catalyze efficient oxygenation of the C18 carbon of steroid substrates.Keywords
This publication has 19 references indexed in Scilit:
- The C494F Variant in the CYP11B1 Gene Is a Sequence Polymorphism in the Spanish PopulationThe Journal of Clinical Endocrinology & Metabolism, 1999
- Mutation THR-185 ILE is associated with corticosterone methyl oxidase deficiency type IIEuropean Journal of Pediatrics, 1998
- Corticosterone methyl oxidase type II (CMO II) deficiency: Biochemical approach to diagnosisClinical Biochemistry, 1994
- Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.Proceedings of the National Academy of Sciences, 1992
- Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency.Proceedings of the National Academy of Sciences, 1992
- The Product of the CYP11B2 Gene Is Required for Aldosterone Biosynthesis in the Human Adrenal CortexMolecular Endocrinology, 1991
- Severe hypoaldosteronism due to corticosterone methyl oxidase type II deficiency in two boys: metabolic and gas chromatography-mass spectrometry studiesEuropean Journal of Pediatrics, 1991
- Simultaneous transfection of COS-1 cells with mitochondrial and microsomal steroid hydroxylases: incorporation of a steroidogenic pathway into nonsteroidogenic cells.Proceedings of the National Academy of Sciences, 1988
- The production of monoclonal antibodies against aldosteroneSteroids, 1987
- Biochemical Diagnosis and Management of Corticosterone Methyl Oxidase Type II DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 1986